Dreman Value Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
MWNA
Dreman Value Management's DGX Position: Q1 2018 in Review
Dreman Value Management reduced its Quest Diagnostics (DGX) stake by 16% in Q1 2018, selling an estimated $155K and leaving 7,786 shares worth $781K. The position accounts for 0.35% of the portfolio, ranked #62.
Dreman Value Management first reported a position in DGX in Q3 2013 and has held it in 19 quarters since. The position peaked at $2.82M in Q1 2014. 653 funds tracked by Wall St. Rank hold DGX as of Q1 2018.
- Dreman Value Management held 7,786 shares of Quest Diagnostics worth $781K as of Q1 2018.
- Dreman Value Management sold 1,512 Quest Diagnostics shares in Q1 2018, an estimated $155K.
- Quest Diagnostics made up 0.35% of Dreman Value Management's portfolio in Q1 2018, its #62 holding.
- Dreman Value Management first reported a position in Quest Diagnostics in Q3 2013 and has held it in 19 quarters since.
- Dreman Value Management's Quest Diagnostics position peaked at $2.82M in Q1 2014.
- 653 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.
Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.